Congenital carnitine deficiency

DBCOND0008341Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic Diseases

Congenital carnitine deficiency is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Primary Carnitine Deficiency
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT740411ICD-10E71.41SNOMED CT21764004MedDRA10062698UMLSC0342788

What you can answer from here — as of November 06, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in

Which approved drugs for Congenital carnitine deficiency share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In